Clinical Trial Update: Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating botulinum toxin type A block of the sphenopalatine ganglion for chronic rhinosinusitis with nasal polyposis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Polyps
• Rhinosinusitis

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Chronic Disease, Nasal Polyposis | Phase 2 | Status: COMPLETED